NTMT2

NTMT2 (METTL11B/NRMT2) is a protein N-terminal α-amine methyltransferase that functions in the same N-terminal methylation pathway as its paralog NTMT1, recognizing the same N-terminal consensus sequences but acting primarily as a monomethylase rather than installing the full di- and tri-methyl marks (PMID:24090352). Co-expression of both enzymes accelerates trimethylation, indicating that NTMT2 primes substrates for subsequent trimethylation by NTMT1 (PMID:24090352). Beyond this catalytic priming, NTMT2 acts as a noncatalytic activator of NTMT1 through direct complex formation: binding increases NTMT1 activity even when NTMT2's own catalytic activity is abolished (PMID:36889590). This regulatory role is embedded in a higher-order assembly, since NTMT2, NTMT1, and METTL13 can form a trimeric complex in which the inhibitory effect of METTL13 on NTMT1 takes precedence over NTMT2's activating effect (PMID:36889590). NTMT1 and NTMT2 have distinct active-site properties, as a bisubstrate-analogue inhibitor shows >3000-fold selectivity for NTMT1 over NTMT2 (PMID:32605369). No NTMT2-exclusive in vivo substrate has been identified in the available corpus, consistent with a primary regulatory rather than independent catalytic function (PMID:36647772).

1. 2013 High

   Establishing whether NTMT2 is an independent methyltransferase or a distinct activity within the N-terminal methylation pathway showed it is a monomethylase that primes substrates for NTMT1-mediated trimethylation, defining a two-enzyme catalytic relationship.

   Evidence In vitro enzyme activity assays and mass spectrometry comparing NTMT1 and NTMT2 catalytic outputs

   PMID:24090352

   Open questions at the time

   • No in vivo demonstration of sequential priming in cells
   • Physiological substrates of NTMT2 monomethylation not defined
2. 2013 Medium

   Comparing the tissue expression and subcellular localization of the two paralogs addressed whether NTMT2 could plausibly act on the same substrate pool as NTMT1, finding shared expression and localization patterns.

   Evidence Tissue expression profiling and cellular localization comparison of NTMT1 and NTMT2

   PMID:24090352

   Open questions at the time

   • No functional consequence of localization demonstrated
   • Localization not resolved to a specific compartment in this evidence
3. 2020 Medium

   Whether NTMT1 and NTMT2 have distinguishable active sites was tested with bisubstrate-analogue inhibitors, revealing >3000-fold selectivity for NTMT1 and confirming the paralogs are biochemically distinct enzymes.

   Evidence In vitro enzyme inhibition assays comparing Ki,app for NTMT1 versus NTMT2

   PMID:32605369

   Open questions at the time

   • Structural basis of the selectivity not resolved
   • Result incidental to a primary NTMT1-focused study
4. 2023 High

   The question of whether NTMT2 regulates NTMT1 beyond catalytic priming was answered by showing direct complex formation activates NTMT1 in a manner independent of NTMT2's catalytic activity, establishing a noncatalytic regulatory function.

   Evidence Reciprocal co-immunoprecipitation, in vitro methylation assays, and catalytic-dead mutant analysis

   PMID:36889590

   Open questions at the time

   • Structural basis of NTMT2-NTMT1 complex unknown
   • Cellular conditions controlling complex formation not defined
5. 2023 Medium

   Placing the NTMT2-NTMT1 interaction in a broader regulatory context showed a trimeric complex with METTL13 in which METTL13's inhibition of NTMT1 overrides NTMT2's activation, defining a hierarchy of regulation.

   Evidence Co-immunoprecipitation and in vitro methylation assays with combinations of all three proteins

   PMID:36889590

   Open questions at the time

   • Stoichiometry and architecture of the trimeric complex unknown
   • In vivo relevance and regulation of the hierarchy not established
6. 2023 Low

   Synthesis of substrate-identification efforts addressed whether NTMT2 has an exclusive catalytic role, concluding no NTMT2-specific in vivo substrate exists and pointing to a primary regulatory function.

   Evidence Review and synthesis of prior substrate identification experiments

   PMID:36647772

   Open questions at the time

   • Negative-result synthesis, not a new direct experiment
   • Cannot exclude an undiscovered NTMT2-exclusive substrate

• It remains unknown what physiological signals control assembly of the NTMT2-NTMT1-METTL13 complex and what cellular processes depend on NTMT2's noncatalytic activation of NTMT1.
• No in vivo phenotype attributed to NTMT2 regulatory function
• Structural model of any NTMT2-containing complex absent